Why the study?
Does the 5-HTTLPR SS genotype increase the risk of new onset depression in patients who underwent pacemaker implantation?
Does the 5-HTTLPR SS genotype increase the risk of new onset depression in patients who underwent pacemaker implantation?
The 5-HTTLPR SS genotype is a significant risk factor for new-onset depression following pacemaker implantation, particularly in women and smokers.
May support targeted post-PM depression monitoring in SS carriers; leaves open causal inference and clinical utility pending prospective validation.
AIM: To study the role of serotonin transporter gene (5-HTTLPR) polymorphisms in the incidence of depression in a Chinese cohort who underwent pacemaker (PM) implantation. METHODS: A total of 294 patients treated with PMs were enrolled. The 5-HTTLPR gene polymorphism was determined. RESULTS: We found that the 5-HTTLPR SS genotype was significantly associated with the risk of depression after PM implantation (odds ratio=3.916, compared with LL carriers, P<0.001), especially in female patients and patients who are smokers. Female SS genotype carries 9.75 times higher risk for depression, and smokers with the SS genotype had 9.45 times higher risk for new onset of depression after the procedure. Pace mode had no influence on the onset of depression. CONCLUSION: This study suggests a significant association between the 5-HTTLPR gene polymorphism and the new onset of depression after PM implantation, especially in women or those who were smokers.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: